Eli Lilly warns of temporary short supply of two insulin products

Drugmaker Eli Lilly warned this week that two of its formulations of insulin would be temporarily out of stock through the beginning of April, citing a ‘brief delay in manufacturing.’ The 10-milliliter vials of Humalog and insulin lispro injection will be in short supply at wholesalers and some pharmacies. More than 8 million people in the US rely on insulin to survive. Although other forms are available, it’s not always simple for patients to switch between different brands of insulin or delivery methods. Lilly said it is moving with urgency to address the supply challenge.